How does the USPTO handle conflicting instructions in patent application submissions?
The USPTO has specific procedures for handling conflicting instructions in patent application submissions: As per 37 CFR 1.495(g), applications with conflicting instructions regarding treatment under 35 U.S.C. 111(a) or 371 will be treated as national stage submissions under 35 U.S.C. 371. The MPEP states: “Where applicant’s initial submission under 35 U.S.C. 371 contains conflicting instructions…
Read MoreWhat can be included in a submission under the Transitional After-Final Practice?
A submission under the Transitional After-Final Practice can include various types of information and amendments. According to MPEP 706.07(g): The submission under 37 CFR 1.129(a) may comprise, but is not limited to, an information disclosure statement (IDS), an amendment to the written description, claims or drawings, a new substantive argument and/or new evidence in support…
Read MoreCan I use any Priority Mail Express® service for patent application submissions?
Can I use any Priority Mail Express® service for patent application submissions? No, not all Priority Mail Express® services are acceptable for patent application submissions. The USPTO specifically requires the use of USPS Priority Mail Express® service. According to MPEP 513: “The Priority Mail Express® Post Office to Addressee service is the only USPS overnight…
Read More